Gene Therapy in 2024: 'Persistent' Approvals, Layoffs, and In Vivo Moving Toward the Clinic
12/18/2024
2024 was a banner year of "firsts" in the gene therapy space, as the US Food and Drug Administration greenlit three new products and expanded indications for two others, all for rare diseases. Continue reading here:
